ClinicalTrials.Veeva

Menu

Measurement of Fibrinogen in Patients With Systemic Inflammatory Response Syndrome (SIRS), Sepsis or Chronicle Liver Disease on Intensive Care Units (ICU)

J

Johann Wolfgang Goethe University Hospital

Status

Unknown

Conditions

SIRS
Liver Disease
Sepsis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

In this study patients with

  1. chronicle liver diseases

    • primary biliary cirrhosis
    • primary sclerosing cholangitis
    • alcoholic liver cirrhosis
    • hepatitis b or C
    • Wilson's disease
    • cryptogenic cirrhosis
  2. Septic Inflammatory Response Syndrome (SIRS)

    • sepsis
    • septic shock
  3. patients after lysis

should be included

Blood samples will be gathered from the patients to measure fibrinogen with 5 different methods.

The methods are:

  • Clauss fibrinogen
  • PT-Derived fibrinogen
  • immunoturbidimetric method
  • heat-precipitated fibrinogen
  • Schulz fibrinogen

The result of these tests will be correlated with laboratory values which are gathered in routine and the clinical outcomes.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • SIRS
  • sepsis
  • septic shock
  • chronicle liver disease (MELD-Score >10)
  • patient after lysis
  • patient agrees

Exclusion criteria

  • no agreement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems